160Tip A Randomized Controlled Phase III Study of Bevacizumab and Paclitaxel in Combination with Atezolizumab As a Treatment for Patients with Locally Advanced or Metastatic Hormone Receptor-Positive HER2-negative Breast Cancer: JCOG1919E/AMBITION Study